About
Hippocrat BioTech Group of Companies

Hippocrat Biotech Group of Companies was founded by Mr. Neeraj Kumar, an M.Sc. in Biotechnology with 18 years of experience in pharmaceutical specialties. The group commenced its journey in 2013 with the incorporation of Hippocrat Biotech Pvt. Ltd., focusing on wholesale, retail, distribution, and exports of pharmaceutical products. In the same year, Biorealm Biopharmaceuticals Pvt. Ltd. was established to specialize in marketing its proprietary brand of dialysis injectables and other pharmaceutical specialty products.
• In 2023, the group undertook a significant expansion by launching Hippocrat Biomedical LLP, a dedicated manufacturing unit for dialysis-related products, supported by a large corporate office. Additionally, Hippocrat Dialysis Services Pvt. Ltd. was founded to provide comprehensive dialysis services, ensuring high-quality care for patients.
• Hippocrat Biotech Group’s growth is driven by its deep understanding of patient needs and healthcare challenges. The company is committed to addressing the emotional and financial burdens faced by kidney failure patients undergoing lifelong dialysis and cancer patients requiring chemotherapy and advanced treatments. With a vision to improve accessibility and affordability of essential medical care, the group strives to contribute meaningfully to healthcare advancements in India and globally.

Our Vision & Mission

Our core values of integrity, sustainability, and compassion drive every aspect of our work, from research and development to manufacturing and distribution.

  • Vision

    To be a globally recognized, R&D-driven pharmaceutical specialty company, equipped with state-of-the-art manufacturing capabilities. Our goal is to develop and deliver costeffective, high-quality, and curative healthcare solutions, improving the well-being of mankind.

  • Mission

    Leveraging the strength of our group companies, we are committed to expanding our footprint across India with 20 branches and extending our reach internationally through exports and specialized services. We strive to be a leading supplier of dialysis-related products and services, catering to hospitals, B2B, and B2C markets with in-house manufactured, high-quality dialysis services. Our mission also includes enhancing dialysis care by establishing hospital-based dialysis units, standalone centers, home dialysis services, and advanced dialysis management solutions, ensuring accessibility, quality, and affordability in renal care.

Our Companies

In 2023, the company expanded significantly by launching its own manufacturing unit for dialysis products under Hippocrat Biomedical LLP, supported by a large corporate office. Additionally, the group established Hippocrat Dialysis Services Pvt. Ltd., dedicated to providing professional dialysis services.

Hippocrat BioTech Pvt. Ltd.

Hippocrat Biotech Pvt. Ltd. is a leading player in the pharmaceutical specialty segment, with a strong focus on delivering high-quality products across the following key therapeutic areas:
Nephrology: Comprehensive dialysis solutions, including dialysis machines, consumables, injectables, and post-transplant immunosuppressive therapies.
Oncology: A specialized portfolio of chemotherapy medications for cancer treatment.
Critical Care: A range of ICU-specific antibiotics and essential injectables.
With dialysis products accounting for 75%-80% of its total business, the company remains committed to advancing renal care solutions.
Core Business Segments
Hippocrat Biotech Pvt. Ltd. has strategically expanded its operations into five key segments.

Hippocrat BioMedical LLP

Hippocrat BioMedical LLP, a key entity within the Hippocrat Group, is dedicated to the manufacturing of high-quality dialysis-related products, catering to the increasing demand within the healthcare sector. Strategically located in Kaman, Vasai, Maharashtra, the state-of-the-art manufacturing facility is positioned to make a significant contribution to the nephrology market. Following 15 months of rigorous setup, the company successfully obtained its first commercial license in January 2025.

Hippocrat Dialysis
Service Pvt. Ltd.

Hippocrat Dialysis Services Pvt Ltd, established in 2023, is dedicated to providing exceptional dialysis services on a contract basis. The company partners with hospitals, trusts, and government institutions for fixed-term agreements, delivering comprehensive, tailored dialysis solutions to meet their specific needs. In addition to in-hospital services, Hippocrat offers home dialysis and ambulance dialysis options, ensuring seamless, accessible care for patients across various settings. With a steadfast commitment to excellence and innovation, Hippocrat Dialysis Services continues to address the evolving healthcare needs of the community.

BioRealm
Biopharmaceuticals Pvt. Ltd.

BioRealm Biopharmaceuticals Pvt. Ltd. is a vital part of our business group, committed to enhancing healthcare solutions in the nephrology sector.
Own Brand Manufacturing: Focused on developing proprietary products designed for dialysis care, produced through third-party manufacturing collaborations.
Franchise Operations: Partnering with renowned pharmaceutical companies to introduce reliable dialysis-related products to the market.
The company operates as a franchise partner for select leading pharmaceutical brands while also producing its own branded products through third-party manufacturing arrangements.

Why Choose us?

Our core values of integrity, sustainability, and compassion drive every aspect of our work, from research and development to manufacturing and distribution.

Our Testimonials

See what our trusted associates and clients have to speak about us

Our Gallery

Take a sneak peek into our infrastructure and facilities
View More

Our Happy Clients

Leave us a Message